Researchers uncovered how the speedy-performing antidepressant ketamine’s results are sustained as time passes in mice.A kind of ketamine often known as esketamine nasal spray was authorized with the FDA in 2019 under the title Spravato to be used in treatment-resistant depression. The drug is offered less than clinical supervision.Research and P